Previously, we demonstrated that the specific peptide inhibitor of mitochondrial μ-calpain, Tat-μCL, protected against retinal degeneration following intravitreal injection or topical eye-drop application in Mertk gene-mutated Royal College of Surgeons rats, one of the animal models of RP. This evidence concerns the gene CAPN2 and retinal degeneration.